AGM
TTOO

Alpine Global Management’s T2 Biosystems, Inc TTOO Stock Holding History

Alpine Global Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3
Closed -$69K – 201
2017
Q4 		$69K Buy
+3
New +$61.9K 0.02% 174

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SH
Sandia Holdings Greenwich, Connecticut $213M AUM 29.35% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Alpine Global Management's TTOO Position: Q1 2018 in Review

Alpine Global Management sold out of T2 Biosystems, Inc (TTOO) in Q1 2018, closing a stake of 3 shares — an estimated $69K sold.

Alpine Global Management first reported a position in TTOO in Q4 2017 and held it in 1 quarter. The position peaked at $69K in Q4 2017. 45 funds tracked by Wall St. Rank hold TTOO as of Q1 2018.

  • Alpine Global Management reported no remaining T2 Biosystems, Inc position as of Q1 2018 after selling out during the quarter.
  • Alpine Global Management sold 3 T2 Biosystems, Inc shares in Q1 2018, an estimated $69K.
  • Alpine Global Management first reported a position in T2 Biosystems, Inc in Q4 2017 and held it in 1 quarter.
  • Alpine Global Management's T2 Biosystems, Inc position peaked at $69K in Q4 2017.
  • 45 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2018.

Based on Alpine Global Management's 13F filing for Q1 2018, filed 16 May 2018.